12.09
SHENZHEN, China, Dec 09, 2009 /PRNewswire-FirstCall via COMTEX/ — Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China based subsidiary Mellow Hope announce that the company has closed its previously announced pending contract worth about $1.8 million. The revenues of this contract will be indicated in subsequent quarterly filings.
In other previously announced news and updates, the batch of MEVAC-DTaP (Diphtheria, tetanus and pertussis vaccine, absorbed) that had been delivered to Thailand undergoes further tests for distribution approval on Thailand’s market. As the tests continue, Mellow Hope invited Thailand’s FDA expert to visit its vaccine production facility in China. The FDA Expert will inspect the facility between 21st-24th December 2009. This invite and the facility inspection aim to speed up the MEVAC-DTaP vaccine registration in Thailand.
Terry Yuan, the CEO of HTDS said, “The FDA expert will scrutinize our production processes and methods used in our production and report his findings to Thailand authorities. We believe that close cooperation with authorities is a key for success in the pharmaceutical industry and we always aim to outperform in this area. We want to be transparent with our customers so they can see we mean business.”
HTDS operates two subsidiaries, Slavica Bio Chem Co. (www.slavicabiochem.com/) and China Mellow Hope Inc. (http://www.mellowhope.com/). China-based Mellow Hope is the biggest exporter of Biological Vaccines in China. It has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestat in. Slavica’s primary focus involves the enhancement and modification of existing approved drugs such as “Virazole” for the purpose of chemical repair of damage to the Central Nervous System, Multiple Sclerosis, SARS, Hepatis C.
To receive future updates via email, including quarterly newsletters and company updates that may not be newsworthy, however important to the reader and followers of the company, please sign up today free at www.minamargroup.com/updates
This is just the beginning of what kinds of conracts and sales that will reflect on the q4′s.
Great job HTDS! let’s close some more deals and put out a great Q4!